These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12475197)

  • 41. Non-peptidic inhibitors of cysteine proteases.
    Schirmeister T; Kaeppler U
    Mini Rev Med Chem; 2003 Jun; 3(4):361-73. PubMed ID: 12678829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Update on drug development targeting parasite cysteine proteases.
    McKerrow JH
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0005850. PubMed ID: 30138309
    [No Abstract]   [Full Text] [Related]  

  • 43. ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis.
    Nicholson DW
    Nat Biotechnol; 1996 Mar; 14(3):297-301. PubMed ID: 9630889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activities.
    Ando R; Sakaki T; Morinaka Y; Takahashi C; Tamao Y; Yoshii N; Katayama S; Saito K; Tokuyama H; Isaka M; Nakamura E
    Bioorg Med Chem; 1999 Apr; 7(4):571-9. PubMed ID: 10353636
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interaction of papain-like cysteine proteases with dipeptide-derived nitriles.
    Löser R; Schilling K; Dimmig E; Gütschow M
    J Med Chem; 2005 Dec; 48(24):7688-707. PubMed ID: 16302809
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasmodium falciparum cysteine protease falcipain-1 is not essential in erythrocytic stage malaria parasites.
    Sijwali PS; Kato K; Seydel KB; Gut J; Lehman J; Klemba M; Goldberg DE; Miller LH; Rosenthal PJ
    Proc Natl Acad Sci U S A; 2004 Jun; 101(23):8721-6. PubMed ID: 15166288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parasite proteases.
    McKerrow JH
    Exp Parasitol; 1989 Jan; 68(1):111-5. PubMed ID: 2645160
    [No Abstract]   [Full Text] [Related]  

  • 48. Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates.
    Royo S; Schirmeister T; Kaiser M; Jung S; Rodríguez S; Bautista JM; González FV
    Bioorg Med Chem; 2018 Sep; 26(16):4624-4634. PubMed ID: 30037754
    [TBL] [Abstract][Full Text] [Related]  

  • 49. General solid-phase method to prepare novel cyclic ketone inhibitors of the cysteine protease cruzain.
    Huang L; Ellman JA
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2993-6. PubMed ID: 12270191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The synthesis of parasitic cysteine protease and trypanothione reductase inhibitors.
    Chibale K; Musonda CC
    Curr Med Chem; 2003 Sep; 10(18):1863-89. PubMed ID: 12871109
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of cysteine proteases by peptides containing aziridine-2,3-dicarboxylic acid building blocks.
    Schirmeister T
    Biopolymers; 1999; 51(1):87-97. PubMed ID: 10380356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of mammalian cathepsins by Plesiomonas shigelloides.
    Pavlova A; Krovácek K; Ciznár I; Gonzalez-Rey C
    Folia Microbiol (Praha); 2006; 51(5):393-400. PubMed ID: 17176758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitric oxide inhibits cruzipain, the major papain-like cysteine proteinase from Trypanosoma cruzi.
    Venturini G; Salvati L; Muolo M; Colasanti M; Gradoni L; Ascenzi P
    Biochem Biophys Res Commun; 2000 Apr; 270(2):437-41. PubMed ID: 10753643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering alpha(1)-antitrypsin to inhibit cathepsin proteases.
    Irving JA; Pike RN; Dai W; Brömme D; Worrall DM; Silverman GA; Coetzer TH; Dennison C; Bottomley SP; Whisstock JC
    Biochemistry; 2002 Apr; 41(15):4998-5004. PubMed ID: 11939796
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ficin: a cysteine proteinase with binding site-catalytic site signalling characteristics intermediate between those of papain and actinidin.
    Patel M; Thomas MP; Kayani IS; Mellor GW; Thomas EW; Brocklehurst K
    Biochem Soc Trans; 1993 May; 21(2):216S. PubMed ID: 8359466
    [No Abstract]   [Full Text] [Related]  

  • 56. Design and synthesis of protein-protein interaction mimics as Plasmodium falciparum cysteine protease, falcipain-2 inhibitors.
    Rizzi L; Sundararaman S; Cendic K; Vaiana N; Korde R; Sinha D; Mohmmed A; Malhotra P; Romeo S
    Eur J Med Chem; 2011 Jun; 46(6):2083-90. PubMed ID: 21429631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective targeting of lysosomal cysteine proteases with radiolabeled electrophilic substrate analogs.
    Bogyo M; Verhelst S; Bellingard-Dubouchaud V; Toba S; Greenbaum D
    Chem Biol; 2000 Jan; 7(1):27-38. PubMed ID: 10662686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Revealing the inhibitory potential of Yersinia enterocolitica on cysteine proteases of the papain family.
    Kędzior M; Pawlak A; Seredyński R; Bania J; Platt-Samoraj A; Czemplik M; Klausa E; Bugla-Płoskońska G; Gutowicz J
    Microbiol Res; 2018 Mar; 207():211-225. PubMed ID: 29458857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dipeptide-derived nitriles containing additional electrophilic sites: potentially irreversible inhibitors of cysteine proteases.
    Löser R; Gütschow M
    J Enzyme Inhib Med Chem; 2009 Dec; 24(6):1245-52. PubMed ID: 19912058
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review: novel cysteine proteases of the papain family.
    Bühling F; Fengler A; Brandt W; Welte T; Ansorge S; Nägler DK
    Adv Exp Med Biol; 2000; 477():241-54. PubMed ID: 10849751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.